EMERSON PERIN

TitleClinical Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Medicine
Address6770 Bertner Ave
Houston, TX 77030
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    P20HL101438     (GREGORIC, IGOR)Jan 15, 2010 - Dec 31, 2012
    NIH/NHLBI
    Combined Stem Cell and Assist Device Therapy for Heart Failure
    Role: Co-Principal Investigator

    RC1EB010791     (PERIN, EMERSON CARVALHO)Sep 30, 2009 - Aug 31, 2012
    NIH/NIBIB
    Gadonanotubes as New MRI Nanolabels for Stem Cell Tracking
    Role: Principal Investigator

    UM1HL087365     (WILLERSON, JAMES T.)Jan 1, 2007 - Feb 28, 2019
    NIH/NHLBI
    Cardiovascular Cell Therapy Research Network
    Role: Co-Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Borow KM, Yaroshinsky A, Greenberg B, Perin EC. Phase 3 DREAM-HF Trial of Mesenchymal Precursor Cells in Chronic Heart Failure. Circ Res. 2019 07 19; 125(3):265-281. PMID: 31318648; PMCID: PMC6688717.
      Citations: 17     Fields:    Translation:HumansCells
    2. Cho SY, Moghaddam SE, Cheong BY, Willerson JT, Perin EC, Wilson LJ, Hern?ndez-Rivera M, Cabreira-Hansen MDG. Labeling Stem Cells with a New Hybrid Bismuth/Carbon Nanotube Contrast Agent for X-Ray Imaging. Contrast Media Mol Imaging. 2019; 2019:2183051. PMID: 31281232; PMCID: PMC6594287.
      Citations:    Fields:    Translation:HumansAnimalsCells
    3. Fanaroff AC, Morrow V, Krucoff MW, Seltzer JH, Perin EC, Taylor DA, Miller LW, Zeiher AM, Losordo DW, Henry TD, Povsic TJ, Fern?ndez-Avil?s F. A Path Forward for Regenerative Medicine. Circ Res. 2018 08 03; 123(4):495-505. PMID: 30355250.
      Citations: 3     Fields:    Translation:HumansAnimals
    4. Moghaddam SE, Zaibaq NG, Ajala A, Mowlazadeh-Haghighi S, Willerson JT, Perin EC, Muthupillai R, Wilson LJ, Hern?ndez-Rivera M, da Gra?a Cabreira-Hansen M. A New High-Performance Gadonanotube-Polymer Hybrid Material for Stem Cell Labeling and Tracking by MRI. Contrast Media Mol Imaging. 2018; 2018:2853736. PMID: 30116161; PMCID: PMC6079544.
      Citations: 3     Fields:    Translation:AnimalsCells
    5. Bolli R, Hare JM, March KL, Pepine CJ, Willerson JT, Perin EC, Yang PC, Henry TD, Traverse JH, Mitrani RD, Khan A, Hernandez-Schulman I, Taylor DA, DiFede DL, Chugh A, Loughran J, Vojvodic RW, Sayre SL, Bettencourt J, Cohen M, Ebert RF, Simari RD, Cardiovascular Cell Therapy Research Network (CCTRN), Lima JAC, Moy? L. Rationale and Design of the CONCERT-HF Trial (Combination of Mesenchymal and c-kit+ Cardiac Stem Cells As Regenerative Therapy for Heart Failure). Circ Res. 2018 06 08; 122(12):1703-1715. PMID: 29703749; PMCID: PMC5993622.
      Citations: 41     Fields:    Translation:HumansCellsCTClinical Trials
    6. Bolli R, Hare JM, Henry TD, Lenneman CG, March KL, Miller K, Pepine CJ, Perin EC, Traverse JH, Willerson JT, Yang PC, Gee AP, Vojvodic RW, Sayre SL, Bettencourt J, Cohen M, Ebert RF, Simari RD, Cardiovascular Cell Therapy Research Network (CCTRN), Lima JA, Moy? L. Rationale and Design of the SENECA (StEm cell iNjECtion in cAncer survivors) Trial. Am Heart J. 2018 07; 201:54-62. PMID: 29910056; PMCID: PMC7282462.
      Citations: 11     Fields:    Translation:HumansCTClinical Trials
    7. Perin EC, Taylor DA. Texas Heart Institute International Symposium on Cardiovascular Regenerative Medicine. Circ Res. 2018 01 19; 122(2):205-206. PMID: 29348248; PMCID: PMC5789798.
      Citations:    Fields:    Translation:Humans
    8. Traverse JH, Henry TD, Pepine CJ, Willerson JT, Chugh A, Yang PC, Zhao DXM, Ellis SG, Forder JR, Perin EC, Penn MS, Hatzopoulos AK, Chambers JC, Baran KW, Raveendran G, Gee AP, Taylor DA, Ebert RF, Simari RD, Moy? L. TIME Trial: Effect of Timing of Stem Cell Delivery Following ST-Elevation Myocardial Infarction on the Recovery of Global and Regional Left Ventricular Function: Final 2-Year Analysis. Circ Res. 2018 02 02; 122(3):479-488. PMID: 29208679; PMCID: PMC5805626.
      Citations: 20     Fields:    Translation:Humans
    9. Mohl W, Henry TD, Milasinovic D, Nguemo F, Hescheler J, Perin EC. From state-of-the-art cell therapy to endogenous cardiac repair. EuroIntervention. 2017 Aug 25; 13(6):760-772. PMID: 28844036.
      Citations: 3     Fields:    Translation:Humans
    10. Iliescu CA, Cilingiroglu M, Giza DE, Rosales O, Lebeau J, Guerrero-Mantilla I, Lopez-Mattei J, Song J, Silva G, Loyalka P, Paixao ARM, Yusuf SW, Perin E, Anderson VH, Marmagkiolis K. "Bringing on the light" in a complex clinical scenario: Optical coherence tomography-guided discontinuation of antiplatelet therapy in cancer patients with coronary artery disease (PROTECT-OCT registry). Am Heart J. 2017 Dec; 194:83-91. PMID: 29223438.
      Citations: 7     Fields:    Translation:Humans
    11. Shatila W, Perin E, Pe?alver JL. Optical Coherence Tomographic Evaluation of Hyperacute Bivalirudin-Induced Coronary Stent Thrombosis. Tex Heart Inst J. 2017 Aug; 44(4):266-268. PMID: 28878581; PMCID: PMC5577953.
      Citations:    Fields:    Translation:Humans
    12. Martin JF, Perin EC, Willerson JT. Direct Stimulation of Cardiogenesis: A New Paradigm for Treating Heart Disease. Circ Res. 2017 06 23; 121(1):13-15. PMID: 28642324; PMCID: PMC5545096.
      Citations: 3     Fields:    Translation:HumansAnimalsCells
    13. Perin EC, Murphy MP, March KL, Bolli R, Loughran J, Yang PC, Leeper NJ, Dalman RL, Alexander J, Henry TD, Traverse JH, Pepine CJ, Anderson RD, Berceli S, Willerson JT, Muthupillai R, Gahremanpour A, Raveendran G, Velasquez O, Hare JM, Hernandez Schulman I, Kasi VS, Hiatt WR, Ambale-Venkatesh B, Taylor DA, Resende M, Gee AP, Durett AG, Bloom J, Richman S, G'Sell P, Williams S, Khan F, Gyang Ross E, Santoso MR, Goldman J, Leach D, Handberg E, Cheong B, Piece N, DiFede D, Bruhn-Ding B, Caldwell E, Bettencourt J, Lai D, Piller L, Simpson L, Cohen M, Sayre SL, Vojvodic RW, Ebert RF, Simari RD, Hirsch AT, Cardiovascular Cell Therapy Research Network (CCTRN), Lima JA, Moy? L. Evaluation of Cell Therapy on Exercise Performance and Limb Perfusion in Peripheral Artery Disease: The CCTRN PACE Trial (Patients With Intermittent Claudication Injected With ALDH Bright Cells). Circulation. 2017 Apr 11; 135(15):1417-1428. PMID: 28209728; PMCID: PMC5388585.
      Citations: 16     Fields:    Translation:HumansCellsCTClinical Trials
    14. Contreras A, Orozco AF, Resende M, Schutt RC, Traverse JH, Henry TD, Lai D, Cooke JP, Bolli R, Cohen ML, Pepine CJ, Yang PC, Perin EC, Willerson JT, Taylor DA, Cardiovascular Cell Therapy Research Network (CCTRN), Moy? L. Identification of cardiovascular risk factors associated with bone marrow cell subsets in patients with STEMI: a biorepository evaluation from the CCTRN TIME and LateTIME clinical trials. Basic Res Cardiol. 2017 01; 112(1):3. PMID: 27882430; PMCID: PMC5760218.
      Citations: 3     Fields:    Translation:HumansCells
    15. Venkatesh BA, Nauffal V, Noda C, Fujii T, Yang PC, Bettencourt J, Ricketts EP, Murphy M, Leeper NJ, Ebert RF, Muthupillai R, Bluemke DA, Perin EC, Hirsch AT, Cardiovascular Cell Therapy Research Network (CCTRN), Moy? L, Lima JA. Baseline assessment and comparison of arterial anatomy, hyperemic flow, and skeletal muscle perfusion in peripheral artery disease: The Cardiovascular Cell Therapy Research Network "Patients with Intermittent Claudication Injected with ALDH Bright Cells" (CCTRN PACE) study. Am Heart J. 2017 Jan; 183:24-34. PMID: 27979038; PMCID: PMC5172389.
      Citations: 5     Fields:    Translation:Humans
    16. Henry TD, Pepine CJ, Lambert CR, Traverse JH, Schatz R, Costa M, Povsic TJ, David Anderson R, Willerson JT, Kesten S, Perin EC. The Athena trials: Autologous adipose-derived regenerative cells for refractory chronic myocardial ischemia with left ventricular dysfunction. Catheter Cardiovasc Interv. 2017 Feb 01; 89(2):169-177. PMID: 27148802.
      Citations: 48     Fields:    Translation:Humans
    17. Park K, Lai D, Handberg EM, Perin EC, Pepine CJ, Anderson RD, Moy? L. Association between High Endocardial Unipolar Voltage and Improved Left Ventricular Function in Patients with Ischemic Cardiomyopathy. Tex Heart Inst J. 2016 Aug; 43(4):291-6. PMID: 27547135; PMCID: PMC4979383.
      Citations: 1     Fields:    Translation:Humans
    18. Bhatnagar A, Bolli R, Johnstone BH, Traverse JH, Henry TD, Pepine CJ, Willerson JT, Perin EC, Ellis SG, Zhao DX, Yang PC, Cooke JP, Schutt RC, Trachtenberg BH, Orozco A, Resende M, Ebert RF, Sayre SL, Simari RD, Cogle CR, Taylor DA, Cardiovascular Cell Therapy Research Network (CCTRN), Moy? L. Bone marrow cell characteristics associated with patient profile and cardiac performance outcomes in the LateTIME-Cardiovascular Cell Therapy Research Network (CCTRN) trial. Am Heart J. 2016 09; 179:142-50. PMID: 27595689; PMCID: PMC5014395.
      Citations: 7     Fields:    Translation:HumansCells
    19. Golpanian S, Schulman IH, Ebert RF, Heldman AW, DiFede DL, Yang PC, Wu JC, Bolli R, Perin EC, Simari RD, Wolf A, Hare JM, Cardiovascular Cell Therapy Research Network, Moy? L. Concise Review: Review and Perspective of Cell Dosage and Routes of Administration From Preclinical and Clinical Studies of Stem Cell Therapy for Heart Disease. Stem Cells Transl Med. 2016 Feb; 5(2):186-91. PMID: 26683870; PMCID: PMC4729551.
      Citations: 53     Fields:    Translation:HumansAnimalsCells
    20. Taylor DA, Perin EC, Willerson JT, Zierold C, Resende M, Carlson M, Nestor B, Wise E, Orozco A, Pepine CJ, Henry TD, Ellis SG, Zhao DX, Traverse JH, Cooke JP, Schutt RC, Bhatnagar A, Grant MB, Lai D, Johnstone BH, Sayre SL, Ebert RF, Bolli R, Simari RD, Cogle CR, Cardiovascular Cell Therapy Research Network (CCTRN), Moy? L. Identification of Bone Marrow Cell Subpopulations Associated With Improved Functional Outcomes in Patients With Chronic Left Ventricular Dysfunction: An Embedded Cohort Evaluation of the FOCUS-CCTRN Trial. Cell Transplant. 2016; 25(9):1675-1687. PMID: 26590374; PMCID: PMC5088500.
      Citations: 11     Fields:    Translation:HumansCells
    21. Perin EC, Borow KM, Silva GV, DeMaria AN, Marroquin OC, Huang PP, Traverse JH, Krum H, Skerrett D, Zheng Y, Willerson JT, Itescu S, Henry TD. A Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells in Patients With Ischemic or Nonischemic Heart Failure. Circ Res. 2015 Aug 28; 117(6):576-84. PMID: 26148930.
      Citations: 80     Fields:    Translation:HumansCTClinical Trials
    22. Gizzatov A, Keshishian V, Mackeyev Y, Law JJ, Guven A, Sethi R, Qu F, Muthupillai R, Willerson JT, Perin EC, Ma Q, Bryant RG, Wilson LJ, Hern?ndez-Rivera M, Cabreira-Hansen Mda G. Surfactant-free Gd(3+)-ion-containing carbon nanotube MRI contrast agents for stem cell labeling. Nanoscale. 2015 Jul 28; 7(28):12085-91. PMID: 26119138.
      Citations: 6     Fields:    Translation:AnimalsCells
    23. Willerson JT, Cabreira-Hansen MG, Taylor DA, Perin EC. Changing of the guard? Eur Heart J. 2015 Jul 14; 36(27):1711-3. PMID: 26022009.
      Citations:    Fields:    Translation:Humans
    24. Silva GV, Gahremanpour A, Attizzani GF, Zeng Y, Wang W, Yamamoto H, Kanaya T, Rippy MK, Bezerra HG, Costa MA, Perin E. Comparison of scanning electron microscopy and optical coherence tomography for imaging of coronary bifurcation stents. Catheter Cardiovasc Interv. 2015 Jun; 85(7):1141-9. PMID: 25044710.
      Citations: 1     Fields:    Translation:Animals
    25. Schutt RC, Trachtenberg BH, Cooke JP, Traverse JH, Henry TD, Pepine CJ, Willerson JT, Perin EC, Ellis SG, Zhao DX, Bhatnagar A, Johnstone BH, Lai D, Resende M, Ebert RF, Wu JC, Sayre SL, Orozco A, Zierold C, Simari RD, Cogle CR, Taylor DA, Cardiovascular Cell Therapy Research Network (CCTRN), Moy? L. Bone marrow characteristics associated with changes in infarct size after STEMI: a biorepository evaluation from the CCTRN TIME trial. Circ Res. 2015 Jan 02; 116(1):99-107. PMID: 25406300; PMCID: PMC4282599.
      Citations: 19     Fields:    Translation:HumansCells
    26. Willerson JT, Taylor D, Perin EC. Till truth makes all things plain: human hearts and stem cells. Circ Res. 2014 Nov 07; 115(11):908-10. PMID: 25378531.
      Citations: 1     Fields:    Translation:HumansAnimalsCells
    27. Cogle CR, Wise E, Meacham AM, Zierold C, Traverse JH, Henry TD, Perin EC, Willerson JT, Ellis SG, Carlson M, Zhao DX, Bolli R, Cooke JP, Anwaruddin S, Bhatnagar A, da Graca Cabreira-Hansen M, Grant MB, Lai D, Ebert RF, Olson RE, Sayre SL, Schulman IH, Bosse RC, Scott EW, Simari RD, Pepine CJ, Taylor DA, Cardiovascular Cell Therapy Research Network (CCTRN), Moy? L. Detailed analysis of bone marrow from patients with ischemic heart disease and left ventricular dysfunction: BM CD34, CD11b, and clonogenic capacity as biomarkers for clinical outcomes. Circ Res. 2014 Oct 24; 115(10):867-74. PMID: 25136078; PMCID: PMC4358751.
      Citations: 27     Fields:    Translation:HumansCells
    28. Perin EC, Murphy M, Cooke JP, Henry TD, Bettencourt J, Gahremanpour A, Leeper N, Anderson RD, Hiatt WR, Lima JA, Venkatesh B, Sayre SL, Vojvodic RW, Taylor DA, Ebert RF, Hirsch AT, Cardiovascular Cell Therapy Research Network, Moy? L. Rationale and design for PACE: patients with intermittent claudication injected with ALDH bright cells. Am Heart J. 2014 Nov; 168(5):667-73. PMID: 25440794; PMCID: PMC4254580.
      Citations: 12     Fields:    Translation:HumansCells
    29. Perin EC, Serruys PW, Duckers HJ, Kastrup J, Chamuleau S, Zheng Y, Silva GV, Willerson JT, Sanz-Ruiz R, S?nchez PL, Lasso J, P?rez-Cano R, Alonso-Farto JC, P?rez-David E, Fern?ndez-Santos ME, Fern?ndez-Avil?s F. Adipose-derived regenerative cells in patients with ischemic cardiomyopathy: The PRECISE Trial. Am Heart J. 2014 Jul; 168(1):88-95.e2. PMID: 24952864.
      Citations: 99     Fields:    Translation:HumansCells
    30. Park KE, Henry TD, Perin EC, Sayre SL, Bettencourt J, Vojvodic RW, Olson RE, Pepine CJ, CCTRN, Moy? LA. Implementation of cardovascular cell therapy network trials: challenges, innovation and lessons learned from experience in the CCTRN. Expert Rev Cardiovasc Ther. 2013 Nov; 11(11):1495-502. PMID: 24147517; PMCID: PMC4117343.
      Citations: 1     Fields:    Translation:Humans
    31. Tran LA, Berlin AN, Zheng Y, Sampaio L, Willerson JT, Perin EC, Wilson LJ, Hern?ndez-Rivera M, Bov? C, Cabreira-Hansen Mda G. The use of gadolinium-carbon nanostructures to magnetically enhance stem cell retention for cellular cardiomyoplasty. Biomaterials. 2014 Jan; 35(2):720-6. PMID: 24148239; PMCID: PMC3900574.
      Citations: 8     Fields:    Translation:AnimalsCells
    32. Rivera EJ, Tran LA, Yoon D, Mikos AG, Rusakova IA, Cheong BY, Willerson JT, Perin EC, Wilson LJ, Hern?ndez-Rivera M, Cabreira-Hansen MD. Bismuth@US-tubes as a Potential Contrast Agent for X-ray Imaging Applications. J Mater Chem B. 2013 Oct 07; 1(37). PMID: 24288589; PMCID: PMC3840030.
      Citations: 11     Fields:    
    33. Szady AD, Pepine CJ, Sharma SV, Cogle CR, Perin EC, Ellis SG, Cardiovascular Cell Therapy Research Network (CCTRN), Moy? LA. A critical analysis of clinical outcomes reported in stem cell trials for acute myocardial infarction: some thoughts for design of future trials. Curr Atheroscler Rep. 2013 Aug; 15(8):341. PMID: 23793731; PMCID: PMC3800160.
      Citations: 4     Fields:    Translation:Humans
    34. Madonna R, Taylor DA, Geng YJ, De Caterina R, Shelat H, Perin EC, Willerson JT. Transplantation of mesenchymal cells rejuvenated by the overexpression of telomerase and myocardin promotes revascularization and tissue repair in a murine model of hindlimb ischemia. Circ Res. 2013 Sep 13; 113(7):902-14. PMID: 23780385.
      Citations: 33     Fields:    Translation:AnimalsCells
    35. Hare JM, Bolli R, Cooke JP, Gordon DJ, Henry TD, Perin EC, March KL, Murphy MP, Pepine CJ, Simari RD, Skarlatos SI, Traverse JH, Willerson JT, Szady AD, Taylor DA, Vojvodic RW, Yang PC, Cardiovascular Cell Therapy Research Network, Moy? LA. Phase II clinical research design in cardiology: learning the right lessons too well: observations and recommendations from the Cardiovascular Cell Therapy Research Network (CCTRN). Circulation. 2013 Apr 16; 127(15):1630-5. PMID: 23588961; PMCID: PMC3967793.
      Citations: 24     Fields:    Translation:Humans
    36. Gahremanpour A, Vela D, Zheng Y, Silva GV, Fodor W, Cardoso CO, Baimbridge F, Fernandes MR, Buja LM, Perin EC. Xenotransplantation of human unrestricted somatic stem cells in a pig model of acute myocardial infarction. Xenotransplantation. 2013 Mar-Apr; 20(2):110-22. PMID: 23489741.
      Citations: 4     Fields:    Translation:HumansAnimalsCells
    37. Zheng Y, Sampaio LC, Li K, Silva GV, Cabreira-Hansen M, Vela D, Segura AM, Perin EC, Bov? C. Safety and feasibility of mapping and stem cell delivery in the presence of an implanted left ventricular assist device: a preclinical investigation in sheep. Tex Heart Inst J. 2013; 40(3):229-34. PMID: 23914010; PMCID: PMC3709201.
      Citations: 5     Fields:    Translation:Animals
    38. Traverse JH, Henry TD, Pepine CJ, Willerson JT, Zhao DX, Ellis SG, Forder JR, Anderson RD, Hatzopoulos AK, Penn MS, Perin EC, Chambers J, Baran KW, Raveendran G, Lambert C, Lerman A, Simon DI, Vaughan DE, Lai D, Gee AP, Taylor DA, Cogle CR, Thomas JD, Olson RE, Bowman S, Francescon J, Geither C, Handberg E, Kappenman C, Westbrook L, Piller LB, Simpson LM, Baraniuk S, Loghin C, Aguilar D, Richman S, Zierold C, Spoon DB, Bettencourt J, Sayre SL, Vojvodic RW, Skarlatos SI, Gordon DJ, Ebert RF, Kwak M, Simari RD, Cardiovascular Cell Therapy Research Network (CCTRN), Moy? LA. Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial. JAMA. 2012 Dec 12; 308(22):2380-9. PMID: 23129008; PMCID: PMC3652242.
      Citations: 170     Fields:    Translation:Humans
    39. Kharlamov AN, Duckers HJ, van Beusekom HM, Smits PC, Perin EC, Serruys PW. Do we have a future with transcatheter adventitial delivery of stem cells? Int J Cardiol. 2013 May 10; 165(2):217-21. PMID: 23218580.
      Citations: 2     Fields:    Translation:HumansAnimalsCells
    40. Perin EC, Willerson JT. Buying new soul. J Am Coll Cardiol. 2012 Nov 20; 60(21):2250-1. PMID: 23153847.
      Citations:    Fields:    Translation:HumansAnimals
    41. Willerson JT, Yeh ET, Perin EC. Cytokine profile and ST-elevation myocardial infarction. Circ Res. 2012 Oct 26; 111(10):1256-7. PMID: 23104875.
      Citations:    Fields:    Translation:Humans
    42. Perin EC, Willerson JT, Pepine CJ, Henry TD, Ellis SG, Zhao DX, Silva GV, Lai D, Thomas JD, Kronenberg MW, Martin AD, Anderson RD, Traverse JH, Penn MS, Anwaruddin S, Hatzopoulos AK, Gee AP, Taylor DA, Cogle CR, Smith D, Westbrook L, Chen J, Handberg E, Olson RE, Geither C, Bowman S, Francescon J, Baraniuk S, Piller LB, Simpson LM, Loghin C, Aguilar D, Richman S, Zierold C, Bettencourt J, Sayre SL, Vojvodic RW, Skarlatos SI, Gordon DJ, Ebert RF, Kwak M, Simari RD, Cardiovascular Cell Therapy Research Network (CCTRN), Moy? LA. Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial. JAMA. 2012 Apr 25; 307(16):1717-26. PMID: 22447880; PMCID: PMC3600947.
      Citations: 178     Fields:    Translation:HumansCTClinical Trials
    43. Perin EC, Silva GV, Zheng Y, Gahremanpour A, Canales J, Patel D, Fernandes MR, Keller LH, Quan X, Coulter SA, Moore WH, Herlihy JP, Willerson JT. Randomized, double-blind pilot study of transendocardial injection of autologous aldehyde dehydrogenase-bright stem cells in patients with ischemic heart failure. Am Heart J. 2012 Mar; 163(3):415-21, 421.e1. PMID: 22424012.
      Citations: 38     Fields:    Translation:HumansCTClinical Trials
    44. Fernandes MR, Fish RD, Canales J, Aliota J, Silva GV, Perin EC, Elayda MA, Wilson JM. Restoration of microcirculatory patency after myocardial infarction: results of current coronary interventional strategies and techniques. Tex Heart Inst J. 2012; 39(3):342-50. PMID: 22719142; PMCID: PMC3368452.
      Citations: 4     Fields:    Translation:Humans
    45. Fernandes MR, Silva GV, Perin EC. Contralateral angiography in acute myocardial infarction patients: is less really more? Tex Heart Inst J. 2012; 39(3):365-6. PMID: 22719145; PMCID: PMC3368469.
      Citations:    Fields:    Translation:Humans
    46. Gahremanpour A, Perin EC, Silva G. Carotid artery stenting versus endarterectomy: a systematic review. Tex Heart Inst J. 2012; 39(4):474-87. PMID: 22949763; PMCID: PMC3423268.
      Citations: 8     Fields:    Translation:Humans
    47. Traverse JH, Henry TD, Ellis SG, Pepine CJ, Willerson JT, Zhao DX, Forder JR, Byrne BJ, Hatzopoulos AK, Penn MS, Perin EC, Baran KW, Chambers J, Lambert C, Raveendran G, Simon DI, Vaughan DE, Simpson LM, Gee AP, Taylor DA, Cogle CR, Thomas JD, Silva GV, Jorgenson BC, Olson RE, Bowman S, Francescon J, Geither C, Handberg E, Smith DX, Baraniuk S, Piller LB, Loghin C, Aguilar D, Richman S, Zierold C, Bettencourt J, Sayre SL, Vojvodic RW, Skarlatos SI, Gordon DJ, Ebert RF, Kwak M, Simari RD, Cardiovascular Cell Therapy ResearchNetwork, Moy? LA. Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial. JAMA. 2011 Nov 16; 306(19):2110-9. PMID: 22084195; PMCID: PMC3600981.
      Citations: 167     Fields:    Translation:Humans
    48. Perin EC, Tian M, Marini FC, Silva GV, Zheng Y, Baimbridge F, Quan X, Fernandes MR, Gahremanpour A, Young D, Paolillo V, Mukhopadhyay U, Borne AT, Uthamanthil R, Brammer D, Jackson J, Decker WK, Najjar AM, Thomas MW, Volgin A, Rabinovich B, Soghomonyan S, Jeong HJ, Rios JM, Steiner D, Robinson S, Mawlawi O, Pan T, Stafford J, Kundra V, Li C, Alauddin MM, Willerson JT, Shpall E, Gelovani JG. Imaging long-term fate of intramyocardially implanted mesenchymal stem cells in a porcine myocardial infarction model. PLoS One. 2011; 6(9):e22949. PMID: 21912635; PMCID: PMC3164664.
      Citations: 23     Fields:    Translation:AnimalsCells
    49. Perin EC, Willerson JT. CD34+ autologous human stem cells in treating refractory angina. Circ Res. 2011 Aug 05; 109(4):351-2. PMID: 21817161.
      Citations: 4     Fields:    Translation:HumansAnimalsCells
    50. Gundlach CW, Caivano A, Cabreira-Hansen Mda G, Gahremanpour A, Brown WS, Zheng Y, McIntyre BW, Willerson JT, Dixon RA, Perin EC, Woodside DG. Synthesis and evaluation of an anti-MLC1 ? anti-CD90 bispecific antibody for targeting and retaining bone-marrow-derived multipotent stromal cells in infarcted myocardium. Bioconjug Chem. 2011 Aug 17; 22(8):1706-14. PMID: 21749133; PMCID: PMC3250066.
      Citations: 8     Fields:    Translation:HumansAnimalsCells
    51. Satya K, Dougherty K, Lee VV, Strickman N, Mortazavi A, Achari A, Perin E, Krajcer Z. Determinants and outcomes of asystole during carotid artery stenting. J Endovasc Ther. 2011 Aug; 18(4):513-7. PMID: 21861740.
      Citations: 1     Fields:    Translation:Humans
    52. Murrow J, Esteves F, Galt J, Chen J, Garcia E, Lin J, Lerakis S, Sher S, Khan Pohlel F, Waller EK, Vaughan D, Perin E, Willerson J, Kereiakes D, Preti R, Pecora AL, Quyyumi AA. Characterization of mechanical dyssynchrony measured by gated single photon emission computed tomography phase analysis after acute ST-elevation myocardial infarction. J Nucl Cardiol. 2011 Oct; 18(5):912-9. PMID: 21717276; PMCID: PMC3289993.
      Citations: 6     Fields:    Translation:Humans
    53. Perin EC, Silva G, Gahremanpour A, Canales J, Zheng Y, Cabreira-Hansen MG, Mendelsohn F, Chronos N, Haley R, Willerson JT, Annex BH. A randomized, controlled study of autologous therapy with bone marrow-derived aldehyde dehydrogenase bright cells in patients with critical limb ischemia. Catheter Cardiovasc Interv. 2011 Dec 01; 78(7):1060-7. PMID: 21594960.
      Citations: 25     Fields:    Translation:HumansCellsCTClinical Trials
    54. Perin EC, Silva GV, Henry TD, Cabreira-Hansen MG, Moore WH, Coulter SA, Herlihy JP, Fernandes MR, Cheong BY, Flamm SD, Traverse JH, Zheng Y, Smith D, Shaw S, Westbrook L, Olson R, Patel D, Gahremanpour A, Canales J, Vaughn WK, Willerson JT. A randomized study of transendocardial injection of autologous bone marrow mononuclear cells and cell function analysis in ischemic heart failure (FOCUS-HF). Am Heart J. 2011 Jun; 161(6):1078-87.e3. PMID: 21641354.
      Citations: 60     Fields:    Translation:HumansCells
    55. Perin EC, Silva GV, Vela DC, Zheng Y, Baimbridge F, Gahremanpour A, Quan X, Hahn W, Kim J, Wood K, Kitamura M. Human hepatocyte growth factor (VM202) gene therapy via transendocardial injection in a pig model of chronic myocardial ischemia. J Card Fail. 2011 Jul; 17(7):601-11. PMID: 21703533.
      Citations: 5     Fields:    Translation:HumansAnimals
    56. Quyyumi AA, Waller EK, Murrow J, Esteves F, Galt J, Oshinski J, Lerakis S, Sher S, Vaughan D, Perin E, Willerson J, Kereiakes D, Gersh BJ, Gregory D, Werner A, Moss T, Chan WS, Preti R, Pecora AL. CD34(+) cell infusion after ST elevation myocardial infarction is associated with improved perfusion and is dose dependent. Am Heart J. 2011 Jan; 161(1):98-105. PMID: 21167340.
      Citations: 65     Fields:    Translation:HumansCells
    57. Silva GV, Fernandes MR, Cardoso CO, Sanz RR, Oliveira EM, Jimenez-Quevedo P, Lopez J, Angeli FS, Zheng Y, Willerson JT, Perin EC. A dosing study of bone marrow mononuclear cells for transendocardial injection in a pig model of chronic ischemic heart disease. Tex Heart Inst J. 2011; 38(3):219-24. PMID: 21720456; PMCID: PMC3113121.
      Citations: 2     Fields:    Translation:Animals
    58. Tran LA, Krishnamurthy R, Muthupillai R, Willerson JT, Perin EC, Wilson LJ, Cabreira-Hansen Mda G. Gadonanotubes as magnetic nanolabels for stem cell detection. Biomaterials. 2010 Dec; 31(36):9482-91. PMID: 20965562; PMCID: PMC2976808.
      Citations: 28     Fields:    Translation:AnimalsCells
    59. Perin EC, Silva GV. Cell-based therapy for chronic ischemic heart disease--a clinical perspective. Cardiovasc Ther. 2011 Jun; 29(3):211-7. PMID: 20955540.
      Citations: 7     Fields:    Translation:Humans
    60. Perin EC, Silva GV, Willerson JT. Training on the use of transendocardial delivery of biologics for cardiac regeneration. JACC Cardiovasc Interv. 2010 Sep; 3(9):991. PMID: 20850103.
      Citations: 1     Fields:    Translation:HumansAnimals
    61. Willerson JT, Perin EC, Ellis SG, Pepine CJ, Henry TD, Zhao DX, Lai D, Penn MS, Byrne BJ, Silva G, Gee A, Traverse JH, Hatzopoulos AK, Forder JR, Martin D, Kronenberg M, Taylor DA, Cogle CR, Baraniuk S, Westbrook L, Sayre SL, Vojvodic RW, Gordon DJ, Skarlatos SI, Simari RD, Cardiovascular Cell Therapy Research Network (CCTRN), Moy? LA. Intramyocardial injection of autologous bone marrow mononuclear cells for patients with chronic ischemic heart disease and left ventricular dysfunction (First Mononuclear Cells injected in the US [FOCUS]): Rationale and design. Am Heart J. 2010 Aug; 160(2):215-23. PMID: 20691824; PMCID: PMC2921924.
      Citations: 26     Fields:    Translation:HumansCellsCTClinical Trials
    62. Bezerra H, Perin E, Berger P, Block P, Ramee S, Katz S, Kellet M, Dippel E, Schaer G, Britto S, Cohen S, Costa M. Outcomes of unselected recipients of sirolimus-eluting stents: the Cypher stent U.S. post-marketing surveillance registry. J Invasive Cardiol. 2010 Feb; 22(2):48-55. PMID: 20124586.
      Citations: 1     Fields:    Translation:Humans
    63. Traverse JH, Henry TD, Vaughan DE, Ellis SG, Pepine CJ, Willerson JT, Zhao DX, Simpson LM, Penn MS, Byrne BJ, Perin EC, Gee AP, Hatzopoulos AK, McKenna DH, Forder JR, Taylor DA, Cogle CR, Baraniuk S, Olson RE, Jorgenson BC, Sayre SL, Vojvodic RW, Gordon DJ, Skarlatos SI, Simari RD, Cardiovascular Cell Therapy Research Network, Moy? LA. LateTIME: a phase-II, randomized, double-blinded, placebo-controlled, pilot trial evaluating the safety and effect of administration of bone marrow mononuclear cells 2 to 3 weeks after acute myocardial infarction. Tex Heart Inst J. 2010; 37(4):412-20. PMID: 20844613; PMCID: PMC2929864.
      Citations: 33     Fields:    Translation:HumansCTClinical Trials
    64. Traverse JH, Henry TD, Vaughan DE, Vaughn DE, Ellis SG, Pepine CJ, Willerson JT, Zhao DX, Piller LB, Penn MS, Byrne BJ, Perin EC, Gee AP, Hatzopoulos AK, McKenna DH, Forder JR, Taylor DA, Cogle CR, Olson RE, Jorgenson BC, Sayre SL, Vojvodic RW, Gordon DJ, Skarlatos SI, Moye' LA, Simari RD, Cardiovascular Cell Therapy Research Network (CCTRN). Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction. Am Heart J. 2009 Sep; 158(3):356-63. PMID: 19699857; PMCID: PMC2784639.
      Citations: 44     Fields:    Translation:HumansCellsCTClinical Trials
    65. Silva GV, Fernandes MR, Madonna R, Clubb F, Oliveira E, Jimenez-Quevedo P, Branco R, Lopez J, Angeli FS, Sanz-Ruiz R, Vaughn WK, Zheng Y, Baimbridge F, Canales J, Cardoso CO, Assad JA, Falotico R, Perin EC. Comparative healing response after sirolimus- and paclitaxel-eluting stent implantation in a pig model of restenosis. Catheter Cardiovasc Interv. 2009 May 01; 73(6):801-8. PMID: 19309735.
      Citations: 5     Fields:    Translation:Animals
    66. Pradhan L, Molina J, Perin E, Paniagua D, Rosenstrauch D, Nabzdyk C. Review: auricular chondrocytes - from benchwork to clinical applications. In Vivo. 2009 May-Jun; 23(3):369-80. PMID: 19454501.
      Citations: 4     Fields:    Translation:HumansAnimalsCells
    67. Tuzun E, Oliveira E, Narin C, Khalil H, Jimenez-Quevedo P, Perin E, Silva G. Correlation of ischemic area and coronary flow with ameroid size in a porcine model. J Surg Res. 2010 Nov; 164(1):38-42. PMID: 19577254.
      Citations: 10     Fields:    Translation:Animals
    68. Perin EC, Silva GV. Autologous cell-based therapy for ischemic heart disease: clinical evidence, proposed mechanisms of action, and current limitations. Catheter Cardiovasc Interv. 2009 Feb 15; 73(3):281-8. PMID: 19213080.
      Citations: 7     Fields:    Translation:Humans
    69. Vela DC, Silva GV, Assad JA, Sousa AL, Coulter S, Fernandes MR, Perin EC, Willerson JT, Buja LM. Histopathological study of healing after allogenic mesenchymal stem cell delivery in myocardial infarction in dogs. J Histochem Cytochem. 2009 Feb; 57(2):167-76. PMID: 19001635; PMCID: PMC2628321.
      Citations: 20     Fields:    Translation:AnimalsCells
    70. Silva GV, Sanz-Ruiz R, Oliveira EM, Fernandes MR, Angeli F, Willerson JT, Dohmann HF, Perin EC, Jim?nez-Quevedo P. [Diabetic and nondiabetic patients respond differently to transendocardial injection of bone marrow mononuclear cells: findings from prospective clinical trials in "no-option" patients]. Rev Esp Cardiol. 2008 Jun; 61(6):635-9. PMID: 18570786.
      Citations: 9     Fields:    Translation:HumansCells
    71. Zheng Y, Fernandes MR, Silva GV, Cardoso CO, Canales J, Gahramenpour A, Baimbridge F, Perin EC, da Gra?a Cabreira-Hansen M. Histopathological validation of electromechanical mapping in assessing myocardial viability in a porcine model of chronic ischemia. Exp Clin Cardiol. 2008; 13(4):198-203. PMID: 19343167; PMCID: PMC2663485.
      Citations: 4     
    72. Fernandes MR, Silva GV, Zheng Y, Oliveira EM, Cardoso CO, Canales J, Sanz-Ruiz R, Jimenez-Quevedo P, Baimbridge F, Perin EC. Validation of QwikStar Catheter for left ventricular electromechanical mapping with NOGA XP system. Tex Heart Inst J. 2008; 35(3):240-4. PMID: 18941605; PMCID: PMC2565544.
      Citations: 4     Fields:    Translation:Animals
    73. Perin EC, Silva GV, Assad JA, Vela D, Buja LM, Sousa AL, Litovsky S, Lin J, Vaughn WK, Coulter S, Fernandes MR, Willerson JT. Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a canine model of acute myocardial infarction. J Mol Cell Cardiol. 2008 Mar; 44(3):486-95. PMID: 18061611.
      Citations: 89     Fields:    Translation:AnimalsCells
    74. Fernandes MR, Silva GV, Caixeta A, Rati M, de Sousa e Silva NA, Perin EC. Assessing intermediate coronary lesions: angiographic prediction of lesion severity on intravascular ultrasound. J Invasive Cardiol. 2007 Oct; 19(10):412-6. PMID: 17906342.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    75. Abdel-Latif A, Bolli R, Tleyjeh IM, Montori VM, Perin EC, Hornung CA, Zuba-Surma EK, Al-Mallah M, Dawn B. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med. 2007 May 28; 167(10):989-97. PMID: 17533201.
      Citations: 309     Fields:    Translation:HumansCells
    76. Perin EC, Silva GV, Fernandes MR, Munger T, Pandey A, Sehra R, Talcott M, Bichard CJ, Creed J, Wong JW, Oliveira EM, Zheng Y, Canales J, Cardoso CO, Patterson MS, Serruys PW. First experience with remote left ventricular mapping and transendocardial cell injection with a novel integrated magnetic navigation-guided electromechanical mapping system. EuroIntervention. 2007 May; 3(1):142-8. PMID: 19737699.
      Citations: 11     Fields:    
    77. Younis GA, Gupta K, Mortazavi A, Strickman NE, Krajcer Z, Perin E, Achari A. Predictors of carotid stent restenosis. Catheter Cardiovasc Interv. 2007 Apr 01; 69(5):673-82. PMID: 17351931.
      Citations: 9     Fields:    Translation:Humans
    78. Perin EC, L?pez J. Methods of stem cell delivery in cardiac diseases. Nat Clin Pract Cardiovasc Med. 2006 Mar; 3 Suppl 1:S110-3. PMID: 16501616.
      Citations: 29     Fields:    Translation:HumansAnimalsCells
    79. Perin EC. Stem cell therapy for cardiovascular disease. Tex Heart Inst J. 2006; 33(2):204-8. PMID: 16878627; PMCID: PMC1524698.
      Citations: 4     Fields:    Translation:HumansCells
    80. de Quadros AS, Gottschall CA, Silva GV, Perin EC, Sarmento-Leite R. Hyperexpansion of coronary stents and clinical outcomes. Tex Heart Inst J. 2006; 33(4):437-44. PMID: 17215966; PMCID: PMC1764960.
      Citations: 2     Fields:    Translation:Humans
    81. Willerson JT, Yeh ET, Geng YJ, Perin EC. Blood-derived progenitor cells after recanalization of chronic coronary artery occlusions in humans. Circ Res. 2005 Oct 14; 97(8):735-6. PMID: 16224072.
      Citations:    Fields:    Translation:Humans
    82. Dohmann HF, Perin EC, Takiya CM, Silva GV, Silva SA, Sousa AL, Mesquita CT, Rossi MI, Pascarelli BM, Assis IM, Dutra HS, Castello-Branco RV, Drummond C, Dohmann HJ, Willerson JT, Borojevic R, Assad JA. Transendocardial autologous bone marrow mononuclear cell injection in ischemic heart failure: postmortem anatomicopathologic and immunohistochemical findings. Circulation. 2005 Jul 26; 112(4):521-6. PMID: 16027258.
      Citations: 24     Fields:    Translation:HumansCells
    83. Perin EC, Borojevic R, Silva SA, Souza AL, Silva GV, Rossi MI, Mesquita CT, Dohmann HJ, Dohmann HF, Assad JA. [Sustained improvement in symptoms and exercise capacity up to six months after autologous transendocardial transplantation of bone marrow mononuclear cells in patients with severe ischemic heart disease]. Arq Bras Cardiol. 2005 May; 84(5):360-6. PMID: 15917966.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    84. Silva GV, Litovsky S, Assad JA, Sousa AL, Martin BJ, Vela D, Coulter SC, Lin J, Ober J, Vaughn WK, Branco RV, Oliveira EM, He R, Geng YJ, Willerson JT, Perin EC. Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation. 2005 Jan 18; 111(2):150-6. PMID: 15642764.
      Citations: 256     Fields:    Translation:AnimalsCells
    85. Perin EC. Choosing a drug-eluting stent: a comparison between CYPHER and TAXUS. Rev Cardiovasc Med. 2005; 6 Suppl 1:S13-21. PMID: 15665793.
      Citations: 5     Fields:    Translation:Humans
    86. Perin EC. The use of stem cell therapy for cardiovascular disease. Tex Heart Inst J. 2005; 32(3):390-2. PMID: 16392227; PMCID: PMC1336717.
      Citations: 1     Fields:    Translation:Humans
    87. Perin EC, Silva GV. Stem cell therapy for cardiac diseases. Curr Opin Hematol. 2004 Nov; 11(6):399-403. PMID: 15548994.
      Citations: 8     Fields:    Translation:HumansAnimalsCells
    88. Perin EC, Dohmann HF, Borojevic R, Silva SA, Sousa AL, Silva GV, Mesquita CT, Vaughn WK, Rangel FO, Assad JA, Carvalho AC, Branco RV, Rossi MI, Dohmann HJ, Willerson JT, Bel?m L. Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy. Circulation. 2004 Sep 14; 110(11 Suppl 1):II213-8. PMID: 15364865.
      Citations: 97     Fields:    Translation:HumansCellsCTClinical Trials
    89. Perin EC. Choosing a drug-eluting stent: how are CYPHER and TAXUS different? J Invasive Cardiol. 2004 Sep; 16 Suppl F:12F-16F; discussion 18F-21F. PMID: 23573648.
      Citations:    Fields:    Translation:Humans
    90. Perin E. Transendocardial injection of autologous mononuclear bone marrow cells in end-stage ischemic heart failure patients: one-year follow-up. Int J Cardiol. 2004 Jun; 95 Suppl 1:S45-6. PMID: 15336846.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    91. Silva GV, Perin EC, Dohmann HF, Borojevic R, Silva SA, Sousa AL, Assad JA, Vaughn WK, Mesquita CT, Carvalho AC, Dohmann HJ, Barroso do Amaral E, Coutinho J, Branco R, Oliveira E, Willerson JT, Bel?m L. Catheter-based transendocardial delivery of autologous bone-marrow-derived mononuclear cells in patients listed for heart transplantation. Tex Heart Inst J. 2004; 31(3):214-9. PMID: 15562839; PMCID: PMC521759.
      Citations: 21     Fields:    Translation:HumansCellsCTClinical Trials
    92. Topaz O, Perin EC, Jesse RL, Mohanty PK, Carr M, Rosenschein U. Power thrombectomy in acute ischemic coronary syndromes. Angiology. 2003 Jul-Aug; 54(4):457-68. PMID: 12934766.
      Citations: 1     Fields:    Translation:Humans
    93. Whitlow PL, DeMaio SJ, Perin EC, O'Neill WW, Lasala JM, Schneider JE, McKeever LS, Ezratty AM, Knopf WD, Powers ER, Shawl FA, Eclipse Investigators. One-year results of percutaneous myocardial revascularization for refractory angina pectoris. Am J Cardiol. 2003 Jun 01; 91(11):1342-6. PMID: 12767430.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    94. Perin EC, Dohmann HF, Borojevic R, Silva SA, Sousa AL, Mesquita CT, Rossi MI, Carvalho AC, Dutra HS, Dohmann HJ, Silva GV, Vivacqua R, Rangel FO, Esporcatte R, Geng YJ, Vaughn WK, Assad JA, Mesquita ET, Willerson JT, Bel?m L. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation. 2003 May 13; 107(18):2294-302. PMID: 12707230.
      Citations: 243     Fields:    Translation:HumansCTClinical Trials
    95. Perin EC, Geng YJ, Willerson JT. Adult stem cell therapy in perspective. Circulation. 2003 Feb 25; 107(7):935-8. PMID: 12600902.
      Citations: 20     Fields:    Translation:Humans
    96. Sarmento-Leite R, Silva GV, Dohman HF, Rocha RM, Dohman HJ, de Mattos ND, Carvalho LA, Gottechall CA, Perin EC. Comparison of left ventricular electromechanical mapping and left ventricular angiography: defining practical standards for analysis of NOGA maps. Tex Heart Inst J. 2003; 30(1):19-26. PMID: 12638666; PMCID: PMC152830.
      Citations: 5     Fields:    Translation:Humans
    97. Rocha RM, Silva GV, Perin EC, Gouvea EP, Filho FM, de Albuquerque DC, Gerk AR, Santos VM. Effects of carvedilol therapy on QT-interval dispersion in congestive heart failure: is there a difference in the elderly? Tex Heart Inst J. 2003; 30(3):176-9. PMID: 12959198; PMCID: PMC197313.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    98. Perin EC, DeMaio SJ, George B, O'Neill WW. Percutaneous laser revascularization in patients with chronic total occlusions. J Am Coll Cardiol. 2002 Dec 04; 40(11):2062; author reply 2062-3. PMID: 12475472.
      Citations:    Fields:    Translation:Humans
    99. Baim D, Brady TJ, Casscells SW, Dunne M, Fayad Z, Fuster V, Gazelle S, Heldman A, Hatsukami T, Kinlay S, Lafont A, Lee R, Libby P, Meier B, Muller JE, Naghavi M, O'Donnell C, Perin E, Rekhter M, Rumberger J, Russell M, Schwartz R, Selwyn A, Strauss HW, Tearney G, Tomaru T, Tuzcu EM, Wasserman B. Thoughts on the role of the healing professions and the events of September 11, 2001. Circulation. 2002 Mar 26; 105(12):1509-10. PMID: 11914263.
      Citations:    Fields:    Translation:Humans
    PERIN's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (358)
    Explore
    _
    Co-Authors (19)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _